CSC
ENZN

Cove Street Capital’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Cove Street Capital’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-712,415
Closed -$755K – 124
2015
Q1 		$755K Hold
712,415
– – 0.1% 91
2014
Q4 		$777K Hold
712,415
– – 0.12% 90
2014
Q3 		$769K Buy
+712,415
New +$879K 0.12% 73

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
Ativo Capital Management Chicago, Illinois $115M AUM 19.02% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Cove Street Capital's ENZN Position: Q2 2015 in Review

Cove Street Capital sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2015, closing a stake of 712,415 shares — an estimated $755K sold.

Cove Street Capital first reported a position in ENZN in Q3 2014 and held it in 3 quarters. The position peaked at $777K in Q4 2014. 58 funds tracked by Wall St. Rank hold ENZN as of Q2 2015.

  • Cove Street Capital reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2015 after selling out during the quarter.
  • Cove Street Capital sold 712,415 ENZON PHARMACEUTICALS INC shares in Q2 2015, an estimated $755K.
  • Cove Street Capital first reported a position in ENZON PHARMACEUTICALS INC in Q3 2014 and held it in 3 quarters.
  • Cove Street Capital's ENZON PHARMACEUTICALS INC position peaked at $777K in Q4 2014.
  • 58 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2015.

Based on Cove Street Capital's 13F filing for Q2 2015, filed 13 Aug 2015.